Dopamine and psychosis: Theory, pathomechanisms and intermediate phenotypes
- 24 June 2009
- journal article
- review article
- Published by Elsevier BV in Neuroscience & Biobehavioral Reviews
- Vol. 34 (5), 689-700
- https://doi.org/10.1016/j.neubiorev.2009.06.005
Abstract
Schizophrenia is a chronic, severe, and disabling brain disorder arising from the adverse interaction of predisposing risk genes and environmental factors. The psychopathology is characterized by a wide array of disturbing cognitive, emotional, and behavioral symptoms that interfere with the individual's capacity to function in society. Contemporary pathophysiological models assume that psychotic symptoms are triggered by a dysregulation of dopaminergic activity in the brain, a theory that is tightly linked to the serendipitous discovery of the first effective antipsychotic agents in the early 1950s. In recent years, the availability of modern neuroimaging techniques has significantly expanded our understanding of the key mediator circuits that bridge the gap between genetic susceptibility and clinical phenotype. This paper discusses the pathophysiological concepts, molecular mechanisms and neuroimaging evidence that link psychosis to disturbances in dopamine neurotransmission.This publication has 133 references indexed in Scilit:
- Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophreniaBrain, 2008
- Large recurrent microdeletions associated with schizophreniaNature, 2008
- Substantia nigra/ventral tegmental reward prediction error disruption in psychosisMolecular Psychiatry, 2007
- Epistasis between catechol- O -methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain functionProceedings of the National Academy of Sciences, 2007
- An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and BehaviorCell, 2005
- Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergenceMolecular Psychiatry, 2004
- Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophreniaNature Neuroscience, 2002
- A Neural Substrate of Prediction and RewardScience, 1997
- A Structural Polymorphism of Human Dopamine D2 Receptor D2(Ser311 → Cys)Biochemical and Biophysical Research Communications, 1993
- Dopamine receptor subtype imbalance in schizophreniaLife Sciences, 1987